August 6, 2008
IGI Laboratories Signs Product Development Agreement With CHS
US-based IGI Laboratories has signed a product development agreement with Cancer Health Solutions Resources.
IGI with Cancer Health Solutions Resources (CHS) will develop a Novasome technology based over the counter sunscreen product containing CHS's proprietary ingredients that may enhance the antioxidant effect of normal skin cells.
"Additionally, our Novasome technology offers the added benefit of a unique capability of combining incompatible drug molecules into one product."